Operating Lease, Right-of-Use Asset of Armata Pharmaceuticals, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Armata Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Armata Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $39,917,000, a 5.5% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Armata Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $39,917,000 -$2,334,000 -5.5% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $40,504,000 -$3,167,000 -7.3% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $41,090,000 -$3,153,000 -7.1% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $41,687,000 -$3,030,000 -6.8% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $42,251,000 -$2,635,000 -5.9% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $43,671,000 +$19,000 +0.04% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $44,243,000 +$1,415,000 +3.3% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $44,717,000 +$1,682,000 +3.9% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 $44,886,000 +$10,249,000 +30% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $43,652,000 +$8,631,000 +25% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $42,828,000 +$7,412,000 +21% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $43,035,000 +$7,183,000 +20% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $34,637,000 +$24,106,000 +229% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $35,021,000 +$24,407,000 +230% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $35,416,000 +$24,720,000 +231% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $35,852,000 +$25,062,000 +232% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $10,531,000 -$338,000 -3.1% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $10,614,000 -$342,000 -3.1% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $10,696,000 +$8,857,000 +482% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $10,790,000 +$8,762,000 +432% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $10,869,000 +$8,611,000 +381% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $10,956,000 +$8,256,000 +306% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $1,839,000 +$1,553,000 +543% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $2,028,000 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $2,258,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $2,700,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $286,000 31 Mar 2019 10-Q 06 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.